SDIC Venture Capital

Canton Biologics is a contract development and manufacturing organization based in China that specializes in the research and development of biologic drugs. The company offers a range of services tailored for the biopharmaceutical industry, including clinical and commercial production. Canton Biologics focuses on the development and production of biomacromolecule drugs, such as monoclonal antibodies, double antibodies, fusion proteins, and recombinant proteins. With a commitment to advancing biologic drug development, Canton Biologics plays a pivotal role in supporting the needs of biopharma companies and contract research organizations.

Beijing Surgerii Technology Co., Ltd. specializes in the research, development, production, and sale of minimally invasive surgical robot systems in China. Founded in 2014 and based in Beijing, the company focuses on innovative technologies, particularly the next generation of flexible continuum robotic arms. Surgerii Technology aims to transform clinical practices through its single-hole and porous laparoscopic robot systems, enhancing the standard of care in minimally invasive surgeries. With a commitment to independent research and development, the company leverages its expertise in system design and integration to advance the medical equipment industry in China.

Yuze Semiconductor is a research and development manufacturer of N-type solar monocrystalline silicon rods and silicon wafers. It was established in 2019 and is headquartered in China.

SAFE Pharmaceutical, officially known as Beijing Saifu Medical Research Institute Co., Ltd., operates as a Contract Research Organization (CRO) specializing in pharmaceutical research and development services. The company collaborates with esteemed institutions such as the Shanghai Institute of Materia Medica and the National Drug Safety Evaluation and Research Center, leveraging their expertise to enhance its operational capabilities. With a core team comprised of experienced researchers from prestigious scientific organizations, SAFE Pharmaceutical offers comprehensive services that include R&D consulting, toxicology evaluations, and clinical trial design. This integrated approach allows pharmaceutical developers to efficiently advance their product research and development initiatives, supported by strong technical expertise and management experience in drug development and GLP compliance.

Weishi Energy is a hydrogen fuel cell product research and development manufacturer, focusing on the market operation of hydrogen fuel cell technology, and is committed to promoting the low-carbon sustainable development of human energy. It is mainly engaged in the research and development, production and sales of hydrogen fuel cell products. At present, Weishi Energy has deployed five R&D centers in Shanghai, Baoding, Japan, Germany, and Canada. It has established a culturally diverse and technologically advanced R&D team, and strictly follows the V model development process to create vehicle-level fuel cell power systems and components. The company's main products include fuel cell engines, electric stacks, 35MPa/70MPa on-board hydrogen systems, bottle valves and pressure reducing valves, etc.

Grace Laser Technology Co., Ltd., established in 2014 and headquartered in Beijing, China, specializes in the development of laser devices for various applications, including scientific research, industrial processing, and medical aesthetics. The company is committed to advancing the national laser industry and aims to establish a renowned domestic laser brand. Grace Laser possesses a comprehensive research and development, production, and quality management system, which enables it to deliver high-quality laser products and services to its clients.

GBase is a provider of database software solutions based in China, specializing in the development of products tailored for various industries, including finance, telecommunications, government, energy, transportation, and national defense. The company focuses on enabling enterprises to utilize domestically developed software, which supports their operational needs and enhances data management capabilities. GBase's offerings are designed to meet the specific requirements of its clients, facilitating improved performance and efficiency in data handling across diverse sectors.

Linkingfresh.com, established in 2018 and headquartered in Qingdao, China, operates as an online platform dedicated to commodity trading and international fresh harvesting services. The company facilitates a comprehensive range of offerings, including international warehousing logistics, internet finance, and distribution processing. It serves as a pivotal link in the fresh industry, connecting major international manufacturers from over 20 countries, such as the United States, Canada, and the Netherlands, with participants throughout the fresh industry chain. Linkingfresh.com provides access to thousands of high-quality direct supply products, including fresh animal protein such as pork, beef, poultry, seafood, and various meat products, thereby supporting both international and domestic supply chains.

Viiyong is a manufacturer based in Shenzhen, China, specializing in multi-layer ceramic chip capacitors. Founded in 2001, the company emphasizes research and development to produce high-end capacitor solutions tailored for the automotive electronics industry. Through its innovative approach, Viiyong aims to meet the evolving needs of customers by providing advanced capacitor products that enhance electronic performance and reliability.

Zhiyi Pharmaceutics Inc., established in 2013 and based in Guangzhou, China, specializes in the research and development of next-generation probiotics (NGPs) and live biotherapeutics (LBPs). The company's product pipeline includes SK08, TP2, ZY19, and SK09, all targeted at treating gastrointestinal disorders. Zhiyi Pharmaceutics focuses on innovative drug discovery, with a particular emphasis on the development of its proprietary strain SK08, which is poised to enter clinical trials. The company aims to expand its research into the relationship between human microbiome and disease, including microbial culture groups and pathobionts research, as well as the identification and separation of new functional strains.

TBSTest Technology is a developer and manufacturer of semiconductor test equipment, focusing on integrated circuit automatic test equipment, ATE, and SOC test equipment. It provides testing solutions including hardware, software, test boards, and memory systems, and offers pre-sales and after-sales support. The company serves IC designers and producers as well as scientific research institutions and universities. Founded in 2017, it is based in Beijing with branch offices in Xi’an, Shanghai, and Suwon, South Korea.

G7 is a company that specializes in fleet management systems aimed at optimizing the transportation ecosystem. With a significant installation base of 800,000 cargo vehicles across China, G7 utilizes proprietary hardware devices to gather and analyze data for logistics companies and drivers. The company's platform enables businesses to locate and monitor transportation vehicles, track driver behaviors, and estimate departure and arrival times. Additionally, G7 provides detailed insights on route optimization, fuel consumption, and cargo conditions, such as temperature and humidity, which helps corporate clients and business owners enhance the efficiency of their transportation networks.

Weishi Energy is a hydrogen fuel cell product research and development manufacturer, focusing on the market operation of hydrogen fuel cell technology, and is committed to promoting the low-carbon sustainable development of human energy. It is mainly engaged in the research and development, production and sales of hydrogen fuel cell products. At present, Weishi Energy has deployed five R&D centers in Shanghai, Baoding, Japan, Germany, and Canada. It has established a culturally diverse and technologically advanced R&D team, and strictly follows the V model development process to create vehicle-level fuel cell power systems and components. The company's main products include fuel cell engines, electric stacks, 35MPa/70MPa on-board hydrogen systems, bottle valves and pressure reducing valves, etc.

Inceptio Technology is a developer of autonomous driving heavy-duty trucks based in Shanghai, China, with additional research and development centers in Silicon Valley. Founded in 2018, the company aims to transform line-haul logistics by offering a nationwide freight network that enhances safety, efficiency, and cost-effectiveness for logistic customers. Its autonomous trucks leverage advanced artificial intelligence, new energy technology, and logistics big data to deliver innovative and reliable transportation solutions. By focusing on the integration of these technologies, Inceptio Technology is positioned to provide significant improvements in the logistics sector.

Jaka Robot is a Shanghai-based company that specializes in the development, engineering, manufacturing, and marketing of industrial robots. Founded in 2014, it offers a range of products including the JAKA ZuTM robot, which features a wireless control system compatible with mobile applications, and the JAKA MES system, designed for information integration across various factory departments. Additionally, the company provides conveyor systems, palletizing robot systems, and liner molding machines. Jaka Robot serves multiple industries, including food and beverage, chemical, packaging, electronics, and mechanical processing, positioning itself as a key player in the industrial automation sector.

Zhiyi Pharmaceutics Inc., established in 2013 and based in Guangzhou, China, specializes in the research and development of next-generation probiotics (NGPs) and live biotherapeutics (LBPs). The company's product pipeline includes SK08, TP2, ZY19, and SK09, all targeted at treating gastrointestinal disorders. Zhiyi Pharmaceutics focuses on innovative drug discovery, with a particular emphasis on the development of its proprietary strain SK08, which is poised to enter clinical trials. The company aims to expand its research into the relationship between human microbiome and disease, including microbial culture groups and pathobionts research, as well as the identification and separation of new functional strains.

TBSTest Technology is a developer and manufacturer of semiconductor test equipment, focusing on integrated circuit automatic test equipment, ATE, and SOC test equipment. It provides testing solutions including hardware, software, test boards, and memory systems, and offers pre-sales and after-sales support. The company serves IC designers and producers as well as scientific research institutions and universities. Founded in 2017, it is based in Beijing with branch offices in Xi’an, Shanghai, and Suwon, South Korea.

XuanZhu Pharma is an innovative biopharmaceutical company rooted in China, with a global perspective, focusing on tumors, metabolic diseases, infections, and other fields. It has a layout of the entire industry chain from drug discovery, preclinical research, clinical development, and production and sales.

MabPlex International Ltd is a contract development and manufacturing organization specializing in biopharmaceuticals, including monoclonal antibodies, recombinant proteins, antibody-drug conjugates, and bispecifics. Founded in 2013, the company operates from its headquarters in Yantai, China, and has an additional office in Fremont, California. MabPlex provides a comprehensive range of services that encompass all stages of drug development, from DNA to finished drug products. Its offerings include customized mammalian cell medium, cell banking, and the manufacturing of monoclonal antibody active pharmaceutical ingredients, as well as fill and finish services for biologics and antibody-drug conjugates. The company aims to deliver high-quality solutions for bio-manufacturing to its global partners.

Remegen is a Chinese biopharmaceutical company focused on developing novel biologics, primarily monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs), to address unmet medical needs in life-threatening conditions. Headquartered in Yantai with labs/offices in Beijing and California, Remegen's portfolio includes Telitacicept for systemic lupus erythematosus and Disitamab Vedotin for various cancers.

PhotonIC Technologies is a Shanghai-based company specializing in the development of integrated optoelectronic chips designed for advanced optical networking and Internet of Things (IoT) sensing applications. The firm focuses on creating high-speed, low-power optoelectronic integrated circuits that cater to various sectors, including data centers, 5G transmission, and 3D Time-of-Flight (ToF) smart sensing systems. By leveraging proprietary CMOS technology for chip design and manufacturing, PhotonIC Technologies aims to deliver competitive solutions in terms of performance, energy efficiency, and cost-effectiveness. The company collaborates with research entities and industrial partners to enhance its product offerings and drive innovation in the field of optoelectronics.

Bangsun Technology, based in Hangzhou, China, specializes in developing online payment security software tailored for domestic internet trading companies and financial institutions. Founded in 2010, the company offers a range of solutions, including banking and tripartite payment solutions, as well as services for bank cards, credit cards, and securities. Its product lineup features real-time transaction anti-fraud systems, Internet credit services, data analytics through machine learning, device fingerprinting, and anti-money laundering solutions. Additionally, Bangsun Technology focuses on providing comprehensive risk management services, including application anti-fraud measures and robot defense, to enhance the security of financial transactions.

Beijing Biostar Technologies, Ltd., established in 2002, is a biopharmaceutical company based in Beijing, China. It specializes in the development of anti-tumor chemotherapy biopharmaceutical molecules, with a focus on creating innovative small molecule chemical drugs for cancer treatment. The company was founded by a team of Chinese scientists led by Dr. Tang Li and Dr. Qiu Rongguo, who previously worked in the United States. Biostar Technologies pioneered the creation of new anti-cancer drugs based on epothilone in China and its technology is recognized as being at the international advanced level.

MabPlex International Ltd is a contract development and manufacturing organization specializing in biopharmaceuticals, including monoclonal antibodies, recombinant proteins, antibody-drug conjugates, and bispecifics. Founded in 2013, the company operates from its headquarters in Yantai, China, and has an additional office in Fremont, California. MabPlex provides a comprehensive range of services that encompass all stages of drug development, from DNA to finished drug products. Its offerings include customized mammalian cell medium, cell banking, and the manufacturing of monoclonal antibody active pharmaceutical ingredients, as well as fill and finish services for biologics and antibody-drug conjugates. The company aims to deliver high-quality solutions for bio-manufacturing to its global partners.

BrightGene Bio-Medical Technology Company is a biopharmaceutical firm based in Suzhou, China, specializing in the research, development, manufacturing, and commercialization of innovative medicines and high-quality generic active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). The company has a diverse product pipeline that includes immuno-oncological agents, GLP-1 receptor agonists for type 2 diabetes, and antibody-drug conjugates aimed at treating solid tumors and brain cancers. Additionally, BrightGene develops a variety of treatments such as Eribulin, Trabectedin, and various macromolecules and cytotoxic payloads. Its product offerings span multiple therapeutic areas, including oncology, cardiology, infectious diseases, and immunology. Founded in 2001, BrightGene has positioned itself as a leader in small molecules and nucleotide drugs, focusing on advancing therapeutics across all stages of development.

Video++ is a video-streaming service based in Shanghai, China, that has been operational since April 2014. The company specializes in providing a video content platform that utilizes advanced AI technology for image recognition. This technology allows Video++ to identify and tag various elements within video content, including brands, celebrities, body language, and specific scenes. By enabling advertisers and e-commerce businesses to search for content and objects in a structured format, Video++ enhances the accessibility and utility of video data for commercial purposes. Its services cater to users both within China and internationally.

Bangsun Technology, based in Hangzhou, China, specializes in developing online payment security software tailored for domestic internet trading companies and financial institutions. Founded in 2010, the company offers a range of solutions, including banking and tripartite payment solutions, as well as services for bank cards, credit cards, and securities. Its product lineup features real-time transaction anti-fraud systems, Internet credit services, data analytics through machine learning, device fingerprinting, and anti-money laundering solutions. Additionally, Bangsun Technology focuses on providing comprehensive risk management services, including application anti-fraud measures and robot defense, to enhance the security of financial transactions.

YOYOSYS is a developer of cloud computing software in China, specializing in big data technologies. The company focuses on creating comprehensive solutions that encompass data storage, computing, and analysis. Its client base includes various sectors such as government, public security, transportation, military, telecommunications, finance, power and energy, and retail manufacturing. YOYOSYS is also dedicated to integrating advanced Internet technology into critical information infrastructure, which is vital for national security and economic sustainability.

Zhejiang Bluetron Industrial Internet Information Technology Co., Ltd. is located in Ningbo, Zhejiang, China and is part of the Computer Systems Design and Related Services Industry. There are 4 companies in the Zhejiang Bluetron Industrial Internet Information Technology Co., Ltd. corporate family.

EnmoTech, based in China, specializes in data services. It offers reliable products, services, and solutions for data management, transportation, processing, and application to businesses and organizations. The company focuses on delivering high-quality, efficient data services at competitive prices, aiming to facilitate an agile and intelligent digital future.

Zshield Inc. is a Beijing-based company specializing in cyberspace data security and big data business risk management. Established in 2014, it is recognized as the first high-tech firm in China to leverage big data technologies in addressing emerging information security vulnerabilities. Zshield develops advanced integrated information security solutions that utilize lightweight virtualization, deep learning, and big data analysis to provide effective monitoring of server and terminal security. Its offerings include a comprehensive information security platform and the AndunTM ZS-ISP, which supports both government and enterprise clients in navigating the complexities of modern computing environments, including cloud computing and mobile applications. As traditional security measures struggle to cope with new threats, Zshield's innovative approach aims to fortify businesses against the evolving landscape of information security challenges.

Eucure Biopharma, established in 2016 and headquartered in Beijing, China, is a biotechnology company focused on the discovery and development of innovative immuno-oncology targeted antibodies. Its pipeline comprises eight drug candidates, primarily targeting immune checkpoints, with several in the clinical trial application stage. The company offers services such as antibody production, in vivo and in vitro drug efficacy testing, and aims to improve the survival rate of tumor patients by developing effective antibody treatments.

Realmax is an augmented reality company based in Shanghai, with additional offices in Hong Kong and New York. The company specializes in developing a technology platform that integrates augmented reality and artificial intelligence to enhance data visualization. Realmax's innovative approach allows users to experience a physical environment enriched with computer-generated images, creating an immersive experience that transcends traditional boundaries. This technology serves various applications, including education and industrial uses, facilitating a deeper engagement with digital information in real-world contexts.

Beijing SkyGuard Network Security Technologies LLC, founded in 2015 and based in Beijing, China, specializes in network information security technology services. The company focuses on developing data security technologies that prioritize the protection of individuals and their data. In addition to its core technology offerings, SkyGuard provides consulting services, as well as pre-sales and after-sales technical support for enterprise users, ensuring comprehensive assistance throughout the customer journey.

Eucure Biopharma, established in 2016 and headquartered in Beijing, China, is a biotechnology company focused on the discovery and development of innovative immuno-oncology targeted antibodies. Its pipeline comprises eight drug candidates, primarily targeting immune checkpoints, with several in the clinical trial application stage. The company offers services such as antibody production, in vivo and in vitro drug efficacy testing, and aims to improve the survival rate of tumor patients by developing effective antibody treatments.

Ascentage Pharma is a clinical-stage biotechnology company focused on developing novel small-molecule therapies for cancers, hepatitis B virus (HBV), and age-related diseases. Its pipeline comprises seven drug candidates targeting protein-protein interactions and tyrosine kinases.

Innovent Biologics is a China-based biopharmaceutical company that discovers, develops, manufactures, and commercializes monoclonal antibodies. It operates a platform for antibody therapeutics across oncology, ophthalmology, immunology, and metabolic diseases, with Tyvyt (sintilimab) as its core asset, a PD-1 inhibitor used in first-line and other cancer indications. The company develops a broad pipeline including biosimilars and novel antibodies and provides distribution, consulting, and R&D services. It maintains strategic collaborations with global partners, including a co-development arrangement with MD Anderson Cancer Center and an alliance with Eli Lilly for TYVYT, and has more than 30 collaborations with major pharmaceutical companies. Innovent is listed on the Hong Kong Exchange and maintains manufacturing and development capabilities in China with a growing portfolio of oncology and non-oncology products marketed domestically and internationally.

Twenty First Century Aerospace Technology Co., Ltd is a Beijing-based company specializing in commercial earth observation (EO) satellites and geospatial information services. Founded in 2001, it operates a constellation of small EO satellites, including a 1-meter optical satellite, and manages satellite control and image tasking stations. The company provides a comprehensive range of services throughout the space geo-information value chain, including satellite procurement, data acquisition, image processing, and geo-information services. Its offerings encompass programmed and archived imaging data, value-added images, and various spatial remote sensing services. Additionally, the company develops software for image data processing, smart satellite resource management, and intelligent tasking. Its geo-information services cater to diverse applications, including land cover analysis, change detection, and 3D simulations, supporting sectors such as urban management, natural resources, and emergency response. With a focus on both domestic and international markets, the company leverages self-developed technology and algorithms to deliver high-quality image data and big data solutions for its clients.

Zshield Inc. is a Beijing-based company specializing in cyberspace data security and big data business risk management. Established in 2014, it is recognized as the first high-tech firm in China to leverage big data technologies in addressing emerging information security vulnerabilities. Zshield develops advanced integrated information security solutions that utilize lightweight virtualization, deep learning, and big data analysis to provide effective monitoring of server and terminal security. Its offerings include a comprehensive information security platform and the AndunTM ZS-ISP, which supports both government and enterprise clients in navigating the complexities of modern computing environments, including cloud computing and mobile applications. As traditional security measures struggle to cope with new threats, Zshield's innovative approach aims to fortify businesses against the evolving landscape of information security challenges.